Verified email-pattern data for Centa Longevity is currently limited. You can still use the company insights and contact sections below.
Centa provides the world's most advanced Longevity diagnostics and treatments. We leverage our cutting-edge science and our years of research to battle and defeat Aging head-on.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Ha-Marpe St 3, Jerusalem,israel,9777403,israel
- Industry
- Home Health Care Services
- HQ
- Jerusalem, Israel
Centa Longevity Questions
Centa Longevity's LinkedIn profile is https://il.linkedin.com/company/centa-longevity
Centa Longevity has
1 employees.
View email and phone details for 1
employees at Centa Longevity.
Centa Longevity's industry is
Home Health Care Services
Centa Longevity's top competitors are
Innocan Pharma,
Senseera,
Entera Bio Ltd.,
Pluri,
Omnix Medical,
Virucure Therapeutics,
Aid Genomics,
Point6 Bio,
Centarix,
Seevix Material Sciences.
Centa Longevity's categories are Home Health Care Services
Centa Longevity's founding year is 2023
Explore related pages
Related company profiles:
Companies like Centa Longevity
Top Centa Longevity Employees
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.